Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-14

Clinical Trial Update: Docetaxel in Node Positive Adjuvant Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating docetaxel in node-positive adjuvant breast cancer has completed, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Sanofi | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2011-02-14